Entity Public Float of Processa Pharmaceuticals, Inc. from 31 Dec 2013 to 28 Jun 2024

Taxonomy & unit: dei: USD
Description: The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.
Summary: Processa Pharmaceuticals, Inc. quarterly Entity Public Float in USD history and change rate from 31 Dec 2013 to 28 Jun 2024.
Processa Pharmaceuticals, Inc. Entity Public Float for the quarter ending 28 Jun 2024 was $5,800,000, a 43% decline year-over-year.
Source SEC data: View on sec.gov

Entity Public Float, Quarterly (USD)

Entity Public Float, YoY Quarterly Change (%)

Processa Pharmaceuticals, Inc. Quarterly Entity Public Float (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2024	$5,800,000	-$4,400,000	-43%	28 Jun 2024	10-K	20 Mar 2025	2024	FY
Q2 2023	$10,200,000	-$23,600,000	-70%	30 Jun 2023	10-K	29 Mar 2024	2023	FY
Q2 2022	$33,800,000	-$61,600,000	-65%	30 Jun 2022	10-K	30 Mar 2023	2022	FY
Q2 2021	$95,400,000	+$73,400,000	+334%	30 Jun 2021	10-K/A	02 May 2022	2021	FY
Q2 2020	$22,000,000	-$22,800,000	-51%	30 Jun 2020	10-K	25 Mar 2021	2020	FY
Q2 2019	$44,800,000	+$19,500,000	+77%	28 Jun 2019	10-K	06 Mar 2020	2019	FY
Q2 2018	$25,300,000	+$24,300,000	+2430%	30 Jun 2018	10-K/A	08 Apr 2019	2018	FY
Q2 2017	$1,000,000	-$447,232	-31%	30 Jun 2017	10-K	16 Apr 2018	2017	FY
Q2 2016	$1,447,232	-$2,499,766	-63%	30 Jun 2016	10-K	25 Sep 2017	2016	FY
Q2 2015	$3,946,998	-$3,810,685	-49%	30 Jun 2015	10-K	19 Jun 2017	2015	FY
Q2 2014	$7,757,683			30 Jun 2014	10-K	14 Apr 2015	2014	FY
Q4 2013	$4,592,000			31 Dec 2013	10-K	27 Mar 2014	2013	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.